Studying gut bacteria in ALS patients
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at the bacteria in the digestive system (gut) of people with ALS to see if there is a link with their symptoms. You give a small stool sample and fill out a questionnaire. This could help us understand ALS better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have ALS that is diagnosed as possible, probable, or definite by specific medical criteria.
- You are at least 18 years old.
- You are followed at one of the 18 ALS expert centers in France that are part of this study.
- You have health insurance (social security) in France.
- You do not have another brain disease such as Parkinson's or Alzheimer's.
- You can agree to take part (no guardian or conservatorship).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a comprehensive analysis platform to better understand ALS (and related conditions) and help find ways to “remedy and eliminate” it. If you have ALS or are a healthy control who can safely complete questionnaires and possibly an MRI, you may be able to contribute data that researchers use to improve care.
This study looks at immune cells (called macrophages) from people with ALS and certain related movement or nerve conditions. It aims to better understand how the disease works and may help researchers design future treatments.
This study looks at why some people with ALS lose weight and what factors are involved. It follows patients in France and Germany to better understand weight changes and help improve care.
This trial collects blood and spinal fluid samples from people being checked for ALS. The goal is to find clues (biomarkers) in tiny particles from nerve cells that could help doctors better understand and diagnose ALS.
This study collects a small skin sample (biopsy) from people with ALS, those who carry an ALS gene mutation but have no symptoms, and healthy volunteers. The sample is used to grow cells in the lab to better understand how ALS develops.
This study looks at how much burden (stress and day-to-day strain) ALS creates for both the patient and the main caregiver. It may help shape better ways to support families facing ALS over time.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.